focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Result of AGM

5 Oct 2020 10:45

RNS Number : 1032B
Phimedix PLC
05 October 2020
 

5 October 2020

Phimedix Plc

("Phimedix" or "the Company")

 

Result of Annual General Meeting

 

The Board of Phimedix is pleased to announce the results of the voting on the resolutions at its Annual General Meeting, held earlier today. A poll was held on each of the resolutions and all resolutions were passed by the requisite majority. Resolutions 1-4 (inclusive) were passed as ordinary resolutions and resolution 5 was passed as a special resolution.

The Poll results are set out below:

Resolution

Votes for (incl. Chairman's discretion)

% of votes

Votes against

% of votes

Votes total

% of total voting rights

Abstained

1. The approval of the accounts of the Company for the year ended 31 March 2020

9,685,176

100.00%

Nil

0.00%

9,685,176

28.15%

2,500

2. The re-election of Nicholas Nelson as a Director of the Company

9,006,811

100.00%

Nil

0.00%

9,006,811

26.18%

680,865

3. The re-appointment of Jeffreys Henry LLP as auditors and to authorise the Directors to fix the auditors' remuneration

9,685,176

100.00%

Nil

0.00%

9,685,176

28.15%

2,500

4. To authorise the Directors to allot shares in the Company pursuant to Section 551 of the Act

9,685,176

100.00%

Nil

0.00%

9,685,176

28.15%

2,500

5. To disapply the statutory pre-emption rights under Section 561 of the Act

9,685,176

100.00%

Nil

0.00%

9,685,176

28.15%

2,500

 

~ End ~

 

For further information please contact:

Phimedix Plc

Nicholas Nelson, Director

Ajay Rajpal, Director

Please email any enquiries to nelson@nexfin.org.uk

 

SPARK Advisory Partners Limited (Nominated Adviser)

Mark Brady or Neil Baldwin

www.sparkadvisorypartners.com

 

+44 (0) 203 368 3550

 

SI Capital Ltd (Broker)

Nick Emerson

www.sicapital.co.uk

 

+44 (0)1483 413500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGKELBBBBLXFBK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.